Results 91 to 100 of about 1,146,044 (291)
Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells
Molecular Oncology, EarlyView.We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller +17 more
wiley +1 more source
ارزیابی عملکرد سیستم اطلاعات داروخانهی بیمارستانهای آموزشی، خصوصی و تأمین اجتماعی شهر اصفهان
مدیریت اطلاعات سلامت, 2013 مقدمه: سیستم اطلاعات داروخانه با پشتیبانی از یک رویکرد درمانی و مدیریت مراقبت دارویی یکی از ارکان ضروری نظام سلامت است، تا اطمینان حاصل شود که دارودرمانی با همان سطح ایمنی و کیفیت مانند دیگر درمانها و خدمات، پشتیبانی و ارزیابی میشود.
Sakineh saghaeiannejad Isfahani +5 more
doaj
Erratum to: An Enhanced Security Solution for Electronic Medical Records Based on AES Hybrid Technique with SOAP/XML and SHA-1 [PDF]
, 2015 Miss Laiha Mat Kiah +3 more
openalex +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
Molecular Oncology, EarlyView.We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology, EarlyView.Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
کاربرد مدارک و اطلاعات پزشکی در تحقیقات از دیدگاه پژوهشگران
مدیریت اطلاعات سلامت, 2008 مقدمه: امروزه تحقیقات در علوم مختلف به عنوان ابزاری قدرتمند و شایان توجه جهت ارزیابی آخرین دستاوردهای علمی به كار میرود. مهمترین ابزار راهگشای محققین در علوم پزشکی برای انجام تحقیقات، مدارك و اطلاعات پزشكی بیماران در بایگانیهای بیمارستانها میباشد ...
Sima Ajami, Faeze Kalbasi, Mahnaz Kabiri
doaj
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source